Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q1 2017 · 10-Q
Revenue$137.00K$137.00K−23.0% vs Q1 2016 Net Income-$2.88M-$2.88MN/M vs Q1 2016 EPS Diluted-$0.08-$0.08N/M vs Q1 2016 Operating Income-$2,875,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
Free Cash Flowderived-$2,342,000— Margins · derivedOperating margin-2098.5%−1494.0 pt vs Q1 2016
Net margin-2099.3%−1258.8 pt vs Q1 2016
ended Mar 31, 2017 · filed May 11, 2017 · 41 d after period end